🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Martin Auster

Stock Analyst at Raymond James

(4.53)
# 1,069
Out of 5,144 analysts
210
Total ratings
49.5%
Success rate
13.2%
Average return

Stocks Rated by Martin Auster

Dyne Therapeutics
Nov 12, 2026
Maintained: Buy
Price Target: $37 → $41
Current: $17.99
Upside: +127.90%
Edgewise Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $66 → $85
Current: $47.57
Upside: +78.68%
Alnylam Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $420 → $315
Current: $159.85
Upside: +97.06%
Ascendis Pharma
Sep 15, 2026
Reiterated: Buy
Price Target: $271 → $287
Current: $259.28
Upside: +10.69%
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $72
Current: $46.60
Upside: +54.51%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $40 → $18
Current: $8.62
Upside: +108.82%
Shattuck Labs
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $5.05
Upside: +256.44%
Septerna
Aug 11, 2026
Rated: Buy
Price Target: $53 → $49
Current: $48.56
Upside: +0.91%
Phathom Pharmaceuticals
Jul 31, 2026
Reiterated: Buy
Price Target: $28 → $21
Current: $6.28
Upside: +234.39%
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.8242
Upside: +506.65%
Reiterated: Buy
Price Target: $6 → $7
Current: $1.42
Upside: +392.96%
Downgraded: Hold
Price Target: n/a
Current: $79.54
Upside: -
Reiterated: Buy
Price Target: $76 → $81
Current: $21.96
Upside: +268.85%
Initiated Coverage: Buy
Price Target: $80
Current: $106.82
Upside: -25.11%
Reiterated: Buy
Price Target: $48 → $56
Current: $36.73
Upside: +52.46%
Reiterated: Buy
Price Target: $108 → $117
Current: $87.08
Upside: +34.36%
Reiterated: Buy
Price Target: $21 → $26
Current: $3.42
Upside: +660.23%
Downgraded: Hold
Price Target: n/a
Current: $58.53
Upside: n/a
Reiterated: Buy
Price Target: $26 → $6
Current: $46.20
Upside: n/a
Reiterated: Buy
Price Target: $102 → $100
Current: $58.33
Upside: n/a
Initiated Coverage: Buy
Price Target: $26
Current: $3.74
Upside: n/a
Reiterated: Buy
Price Target: $29 → $12
Current: $23.25
Upside: n/a
Reiterated: Hold
Price Target: $7 → $8
Current: $7.60
Upside: n/a
Reiterated: Buy
Price Target: $49 → $58
Current: $27.76
Upside: n/a
Reiterated: Hold
Price Target: $156 → $72
Current: $16.68
Upside: n/a
Reiterated: Buy
Price Target: $169 → $196
Current: $595.66
Upside: n/a
Reiterated: Buy
Price Target: $62 → $98
Current: $1.12
Upside: n/a
Reiterated: Hold
Price Target: $64 → $99
Current: $16.70
Upside: n/a
Reiterated: Buy
Price Target: $50 → $60
Current: $120.75
Upside: n/a
Reiterated: Hold
Price Target: $53 → $54
Current: $64.91
Upside: n/a
Reiterated: Buy
Price Target: $76 → $78
Current: $24.59
Upside: n/a
Reiterated: Hold
Price Target: $11 → $12
Current: $4.87
Upside: n/a
Reiterated: Hold
Price Target: $21 → $24
Current: $11.41
Upside: n/a
Reiterated: Buy
Price Target: $27 → $43
Current: $7.73
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $484.00
Upside: n/a
Reiterated: Hold
Price Target: $16
Current: $48.77
Upside: n/a
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Initiated Coverage: Buy
Price Target: $17
Current: $1.02
Upside: n/a